nalidixic acid has been researched along with Mycoses in 5 studies
Mycoses: Diseases caused by FUNGI.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Eighty-four cancer patients at risk of infection because of neutropenia were randomized to receive nalidixic acid as an alternative to trimethoprim-sulfamethoxazole (TMP-SMX) for infection prophylaxis." | 5.06 | Selective gut decontamination with nalidixic acid or trimethoprim-sulfamethoxazole for infection prophylaxis in neutropenic cancer patients: relationship of efficacy to antimicrobial spectrum and timing of administration. ( Bow, EJ; Louie, TJ; Rayner, E; Scott, BA, 1987) |
| "Sixty-two profoundly granulocytopenic patients with acute leukemia undergoing induction chemotherapy were prospectively randomized to receive either trimethoprim-sulfamethoxazole plus nystatin or nalidixic acid plus nystatin for prevention of infection." | 5.05 | Selective antimicrobial modulation as prophylaxis against infection during granulocytopenia: trimethoprim-sulfamethoxazole vs. nalidixic acid. ( Crowley, J; de Jongh, CA; Newman, KA; Schimpff, SC; Wade, JC; Wiernik, PH, 1983) |
| " From the published evidence, the most promising associations are, for staphylococcal infections, gentamicin, erythromycin, kanamycin and fusidic acid." | 4.76 | Clinical use of rifampicin in combination for non-mycobacterial infections: a survey of published evidence. ( Fowst, G; Nessi, R, 1979) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hendriks, WD | 1 |
| Sizoo, W | 1 |
| Löwenberg, B | 1 |
| Hagenbeek, A | 1 |
| Wade, JC | 1 |
| de Jongh, CA | 1 |
| Newman, KA | 1 |
| Crowley, J | 1 |
| Wiernik, PH | 1 |
| Schimpff, SC | 1 |
| Nessi, R | 1 |
| Fowst, G | 1 |
| Bow, EJ | 1 |
| Rayner, E | 1 |
| Scott, BA | 1 |
| Louie, TJ | 1 |
| Bláha, M | 1 |
| Vacková, M | 1 |
| Vanásek, J | 1 |
| Splino, M | 1 |
| Jebavý, L | 1 |
| Malý, J | 1 |
| Pecka, M | 1 |
2 reviews available for nalidixic acid and Mycoses
| Article | Year |
|---|---|
[Bacteriologic management of patients with decreased resistance].
Topics: Agranulocytosis; Anti-Bacterial Agents; Antisepsis; Bacterial Infections; Drug Combinations; Humans; | 1984 |
Clinical use of rifampicin in combination for non-mycobacterial infections: a survey of published evidence.
Topics: Amphotericin B; Cephalosporins; Chloramphenicol; Colistin; Drug Therapy, Combination; Endocarditis, | 1979 |
2 trials available for nalidixic acid and Mycoses
| Article | Year |
|---|---|
Selective antimicrobial modulation as prophylaxis against infection during granulocytopenia: trimethoprim-sulfamethoxazole vs. nalidixic acid.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Bacterial Infections; Child; Drug Combinations; Female; Hu | 1983 |
Selective gut decontamination with nalidixic acid or trimethoprim-sulfamethoxazole for infection prophylaxis in neutropenic cancer patients: relationship of efficacy to antimicrobial spectrum and timing of administration.
Topics: Agranulocytosis; Antineoplastic Agents; Bacteria; Bacterial Infections; Clinical Trials as Topic; Dr | 1987 |
1 other study available for nalidixic acid and Mycoses
| Article | Year |
|---|---|
[Selective decontamination of the digestive tract for the prevention of infection in patients with neutropenia].
Topics: Adult; Agranulocytosis; Anti-Infective Agents; Bacterial Infections; Digestive System; Humans; Mycos | 1986 |